Log In
BCIQ
Print this Print this
 

ASP-08126, Debio 1144

  Manage Alerts
Collapse Summary General Information
Company Ascepion Pharmaceuticals Inc.
DescriptionTyrosine kinase inhibitor
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation
PartnerDebiopharm Group

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/18/2012

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today